Sarepta Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $599.7M | $122.4M | $80.3M | $73.6M | $257.0M | $187.7M | $39.9M | $33.6M |
| Accounts Receivable | $29.5M | $5.2M | $4.0M | $2.4M | $3.5M | $4.7M | $3.6M | $3.2M |
| Inventory | $83.6M | $12.8M | — | — | — | — | — | — |
| Total Current Assets | $1.23B | $373.5M | $224.5M | $247.8M | $270.8M | $193.9M | $45.2M | $37.8M |
| Property, Plant & Equipment | $43.2M | $37.8M | $37.3M | $38.5M | $15.0M | $3.4M | $4.3M | $2.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $14.4M | $8.1M | $6.6M | $5.9M | $5.0M | $4.9M | $4.8M | $4.0M |
| Total Assets | $1.31B | $424.1M | $273.8M | $295.0M | $291.6M | $205.0M | $54.4M | $46.0M |
| Liabilities | ||||||||
| Accounts Payable | $8.5M | $29.7M | $20.2M | $12.4M | $8.1M | $7.5M | $9.4M | $1.3M |
| Total Current Liabilities | $88.3M | $75.4M | $62.3M | $36.9M | $36.0M | $78.9M | $20.6M | $45.9M |
| Long-Term Debt | $431.1M | $17.7M | $26.8M | $1.5M | $1.6M | $1.7M | $1.8M | $1.8M |
| Total Liabilities | $518.7M | $87.4M | $83.4M | $47.4M | $44.4M | $81.3M | $23.4M | $48.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.22B | $-1.17B | $-899.1M | $-679.0M | $-543.2M | — | — | — |
| Total Stockholders' Equity | $789.2M | $336.7M | $190.3M | $247.7M | $247.2M | $123.7M | $31.0M | $-2.8M |